Abeona Therapeutics (ABEO)Cable Car Capital, LP added to its stake +1.9M shares

2.5M

Shares reported · +1.9M vs prior quarter

0.45%

Disclosed portfolio weight

$13.2M

Reported value

Holdings as of

Dec 31, 2025

Filed

Feb 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Mar 16, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
2. Mar 17, 2026Company filing · Form 8-K · ResultsReported its results
3. Apr 1, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 1, 2026, the Board of Directors (the “Board”) of Abeona Therapeutics Inc. (the “Company”), acting upon the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Board from nine to ten members and appointed Keith A. Goldan as a member of the Board of the Company as a Class 1 director.”
4. May 13, 2026Company filing · Form 8-K · ResultsReported its results
5. Jun 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors (the “Board”) of Abeona Therapeutics Inc. (the “Company”) effective immediately.”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Abeona Therapeutics

For Abeona Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABEO page.

How this filing works

• SEC Form 13F

Other disclosures at Abeona Therapeutics

• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its ABEO page.